Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients
Conclusion: In patients on hemodialysis, 24-week treatment with ferric citrate hydrate resulted in significant reduction in FGF23 and ERI independently of serum phosphate level.Am J Nephrol 2018;47:406 –414
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Calcium | Carbohydrates | Dialysis | Hemodialysis | Hormones | Iron | Neurology | Study | Urology & Nephrology | Vitamin D | Vitamins